In a large prospective multicenter study conducted at ten South Korean medical sites, the sensitivity and specificity of the PENK methylation test for bladder cancer detection, particularly high-grade or invasive types, were investigated, and its diagnostic accuracy was compared to that of NMP22 and urine cytology tests. The gene discussed is NUMA1; the disease is urinary bladder carcinoma.